Site-specific incorporation of unnatural amino acids into urate oxidase in Escherichia coli

Protein Science

Volumn 17, Issue 10, 2008, Pages 1827-1833

  Chen, Mingjie ^a   Cai, Lei ^a   Fang, Zhengzhi ^a   Tian, Hong ^a   Gao, Xiangdong ^a   Yao, Wenbing ^a,b  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b NONE   (China)

Author keywords

Amber nonsense codon; p azido L phenylalanine; Site directed mutagenesis; Tyrosyl suppressor tRNA aminoacyl tRNA synthetase system; Urate oxidase

Indexed keywords

ALLANTOIN; AMINO ACID; TRANSFER RNA; URATE OXIDASE; URIC ACID;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; AMINOACYLATION; ARTICLE; CRYSTAL STRUCTURE; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME MECHANISM; ENZYME PURIFICATION; ESCHERICHIA COLI; GOUT; IMMUNOGENICITY; NONHUMAN; OXIDATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN STABILITY; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION;

AMINO ACID SUBSTITUTION; AMINO ACIDS; AMINO ACYL-TRNA SYNTHETASES; AZIDES; ESCHERICHIA COLI; MUTAGENESIS, SITE-DIRECTED; PHENYLALANINE; PROTEIN ENGINEERING; RNA, TRANSFER, AMINO ACYL; URATE OXIDASE;

ESCHERICHIA COLI;

EID: 52949092303     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.034587.108     Document Type: Article

References (22)

1. Anderson, J.C., Wu, N., Santoro, S.W., Lakshman, V., King, D.S., and Schultz, P.G. 2004. An expanded genetic code with a functional quadruplet codon. Proc. Natl. Acad. Sci. 101: 7566-7571.
2. Aslan, F.M., Yu, Y., Vajda, S., Mohr, S.C., and Cantor, C.R. 2007. Engineering a novel, stable dimeric streptavidin with lower isoelectric point. J. Biotechnol. 128: 213-225.
3. Bardin, T. 2004. Current management of gout in patients unresponsive or allergic to allopurinol. Joint Bone Spine 71: 481-485.
4. Cammalleri, L. and Malaguarnera, M. 2007. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int. J. Med. Sci. 4: 83-93.
5. Chen, S., Schultz, P.G., and Brock, A. 2007. An improved system for the generation and analysis of mutant proteins containing unnatural amino acids in Saccharomyces cerevisiae. J. Mol. Biol. 371: 112-122.
6. Coiffier, B., Mounier, N., Bologna, S., Fermé, C., Tilly, H., Sonet, A., Christian, B., Casasnovas, O., Jourdan, E., Belhadj, K., et al. 2003. Efficacy and safety of Rasburicase (recombinant urate oxidase) for the prevention and treatment of hyperuricemia during induction chemotherapy of aggressive non-Hodgkin's lymphoma: Results of the GRAAL1 (Groupe d'Etude des Lymphomes de l'Adulte Trial on Rasburicase Activity in Adult Lymphoma) study. J. Clin. Oncol. 21: 4402-4406.
7. Deiters, A., Cropp, T.A., Summerer, D., Mukherji, M., and Schultz, P.G. 2004. Site-specific PEGylation of proteins containing unnatural amino acids. Bioorg. Med. Chem. Lett. 14: 5743-5745.
8. Dougherty, D.A. 2000. Unnatural amino acids as probes of protein structure and function. Curr. Opin. Chem. Biol. 4: 645-652.
9. Gustafsson, C., Govindarajan, S., and Minshull, J. 2004. Codon bias and heterologous protein expression. Trends Biotechnol. 22: 346-353.
10. Hongoh, Y., Sasaki, T., and Ishikawa, H. 2000. Cloning, sequence analysis and expression in Escherichia coli of the gene encoding a uricase from the yeast-like symbiont of the brown planthopper, Nilaparvata lugens. Insect Biochem. Mol. Biol. 30: 173-182.
11. Kim, K.J., Kim, H.E., Lee, K.H., Han, W., Yi, M.J., Jeong, J., and Oh, B.H. 2004. Two-promoter vector is highly efficient for overproduction of protein complexes. Protein Sci. 13: 1698-1703.
12. Li, J., Chen, Z., Hou, L., Fan, H., Weng, S., Xu, C., Ren, J., Li, B., and Chen, W. 2006. High-level expression, purification, and characterization of non-tagged Aspergillus flavus urate oxidase in Escherichia coli. Protein Expr. Purif. 49: 55-59.
13. Oda, M., Satta, Y., Takenaka, O., and Takahata, N. 2002. Loss of urate oxidase activity in hominoids and its evolutionary implications. Mol. Biol. Evol. 19: 640-653.
14. Rodriguez, E.A., Lester, H.A., and Dougherty, D. 2007a. Improved amber and opal suppressor tRNAs for incorporation of unnatural amino acids in vivo. Part 1: Minimizing misacylation. RNA 13: 1703-1714.
15. Rodriguez, E.A., Lester, H.A., and Dougherty, D. 2007b. Improved amber and opal suppressor tRNAs for incorporation of unnatural amino acids in vivo. Part 2: Evaluating suppression efficiency. RNA 13: 1715-1722.
16. Sherman, M.R., Saifer, M.G., and Perez-Ruiz, F. 2008. PEG-uricase in the management of treatment-resistant gout and hyperuricemia. Adv. Drug Deliv. Rev. 60: 59-68.
17. Turner, J.M., Graziano, J., Spraggon, G., and Schultz, P.G. 2006. Structural plasticity of an aminoacyl-tRNA synthetase active site. Proc. Natl. Acad. Sci. 103: 6483-6488.
18. Wang, L. and Schultz, P.G. 2001. A general approach for the generation of orthogonal tRNAs. Chem. Biol. 8: 883-890.
19. Wang, L. and Schultz, P.G. 2005. Expanding the genetic code. Angew Chem. Int Ed Engl. 44: 34-66.
20. Ye, S., Köhrer, C., Huber, T., Kazmi, M., Sachdev, P., Yan, E.C., Bhagat, A., Rajbhandary, U.L., and Sakmar, T.P. 2008. Site-specific incorporation of keto amino acids into functional G protein-coupled receptors using unnatural amino acid mutagenesis. J. Biol. Chem. 283: 1525-1533.
21. Zaremba, M., Sasnauskas, G., Urbanke, C., and Siksnys, V. 2005. Conversion of the tetrameric restriction endonuclease Bse634I into a dimer: Oligomeric structure-stability-function correlations. J. Mol. Biol. 348: 459-478.
22. Zhang, Y., Wang, L., Schultz, P.G., and Wilson, I.A. 2005. Crystal structures of apo wild-type M. jannaschii tyrosyl-tRNA synthetase (TyrRS) and an engineered TyrRS specific for O-methyl-L-tyrosine. Protein Sci. 14: 1340-1349.